Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 22:15:1338235.
doi: 10.3389/fphar.2024.1338235. eCollection 2024.

Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care

Udo Zifko  1 , Katja Guendling  2 , Raymond Seet  3 , Siegfried Kasper  4
Affiliations
Review

Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care

Udo Zifko et al. Front Pharmacol. .

Abstract

Introduction: Although post-COVID-19 syndrome (PCS) with cognitive impairment is increasingly encountered in primary care, evidence-based recommendations for its appropriate management are lacking. Methods: A systematic literature search evaluating the diagnosis and treatment of cognitive impairment associated with PCS was conducted. Practical recommendations for the management of PCS-associated cognitive impairment in primary care are summarized, based on an evaluation of pharmacological plausibility and clinical applications. Results: Currently, the pathology of cognitive impairment associated with PCS remains unclear with no high-quality data to support targeted interventions. Existing treatment approaches are directed towards symptom relief where counseling on the chronicity of the disease and regular reassessments at 4- to 8-week intervals is considered reasonable. Patients should be informed and encouraged to adopt a healthy lifestyle that centers around balanced nutrition and appropriate physical activities. They may also benefit from the intake of vitamins, micronutrients, and probiotics. The administration of Ginkgo biloba extract could offer a safe and potentially beneficial treatment option. Other non-pharmacological measures include physiotherapy, digitally supported cognitive training, and, if indicated, ergotherapy or speech therapy. In most patients, symptoms improve within 8 weeks. If serious, ambiguous, or when new symptoms occur, specialized diagnostic measures such as comprehensive neurocognitive testing or neuroimaging should be initiated. Very few patients would require inpatient rehabilitation. Conclusion: PCS with cognitive impairment is a debilitating condition that could affect daily functioning and reduce work productivity. Management in primary care should adopt a multidisciplinary approach, centering around physical, cognitive, and pharmacological therapies.

Keywords: EGb 761®; Ginkgo biloba extract; cognitive impairment; long-COVID syndrome; management; post-acute covid.

PubMed Disclaimer

Conflict of interest statement

This research received funding from Dr. Willmar Schwabe GmbH & Co. KG. The funder was involved in the study design and data collection. The final decision to submit the article for publication remained with the authors.

Figures

FIGURE 1
FIGURE 1
Flow-chart of systematic literature search.
FIGURE 2
FIGURE 2
Algorithm for pragmatic management of individuals with cognitive impairment associated with post-COVID syndrome in primary care.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Aiello E. N., Fiabane E., Manera M. R., Radici A., Grossi F., Ottonello M., et al. (2022). Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the mini-mental state examination (MMSE) and the Montreal cognitive assessment (MoCA). Neurol. Sci. 43 (1), 81–84. 10.1007/s10072-021-05630-3 - DOI - PMC - PubMed
    1. Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., McMullan C., Chandan J. S., et al. (2021). Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 114 (9), 428–442. 10.1177/01410768211032850 - DOI - PMC - PubMed
    1. Astin R., Banerjee A., Baker M. R., Dani M., Ford E., Hull J. H., et al. (2023). Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 108 (1), 12–27. 10.1113/EP090802 - DOI - PMC - PubMed
    1. Bachmeier B. E., Holzle S., Gasser M., van den Akker M. (2023). How do German general practitioners manage long-/post-COVID? A qualitative study in primary care. Viruses 15 (4), 1016. 10.3390/v15041016 - DOI - PMC - PubMed
    1. Barrea L., Vetrani C., Caprio M., Cataldi M., Ghoch M. E., Elce A., et al. (2022). From the ketogenic diet to the mediterranean diet: the potential dietary therapy in patients with obesity after CoVID-19 infection (post CoVID syndrome). Curr. Obes. Rep. 11 (3), 144–165. 10.1007/s13679-022-00475-z - DOI - PMC - PubMed

LinkOut - more resources